Badiavas Kosmas, Chatzopoulos Dimitrios, Markou Pavlos
9 Melenikou Str., 582 00 Edessa, Macedonia, Greece.
Hell J Nucl Med. 2006 Jan-Apr;9(1):65-8.
The present study was undertaken because we could not find references related to the minimal radiation doses emitted from patients treated with (90)Y-silicate colloid ((90)Y-SC) for radiosynectomy (RS). Radiation doses from 16 patients treated with about 181+/-13 MBq (90)Y-SC for RS of knee synovitis were estimated by dose rate measurements performed within 10 min after the (90)Y-SC injection with a calibrated survey dose ratemeter at 0.5 m, 1 m and 2 m distances from the treated joint. The mean dose rate values from the patients after bg subtraction were 0.6+/-0.4 microSv/h at 0.5 m, 0.1+/-0.1 microSv/h at 1 m and 0.1 +/- 0.0 microSv/h at 2 m distance. Dose rates at a distance of 0.5 m were significantly correlated (P<0.02) with the patient's weight but not with the height or the injected activity. The assumed estimated maximum whole body doses from a treated patient were 55 microSv for persons living with the patient, 2.9-3.4 microSv for the nursing staff, 0.2-1.8 microSv for the therapist physician and 0.3-0.6 microSv for the technologist, involved in the whole procedure. The above values were lower than those published with the same methodology for alternative RS radiopharmaceuticals for knee synovitis like dysprosium-165 ferric hydroxide macroaggregate ((165)Dy-FHMA) or holmium-166 ((166)Ho-FHMA), as estimated with their typical injected activities. In conclusion our results demonstrate that in (90)Y-SC knee synovectomy, the whole body radiation doses to medical and non medical personnel were as expected well below the maximum annual dose limits for the public and professionals exposed to radiation.
开展本研究是因为我们未能找到与接受(90)Y-硅酸盐胶体((90)Y-SC)放射性滑膜切除术(RS)治疗的患者所发出的最小辐射剂量相关的参考文献。通过在(90)Y-SC注射后10分钟内,使用校准的剂量率测量仪在距治疗关节0.5米、1米和2米的距离处进行剂量率测量,估算了16例接受约181±13MBq(90)Y-SC治疗膝关节滑膜炎的RS患者的辐射剂量。扣除本底后患者的平均剂量率值在0.5米处为0.6±0.4微希沃特/小时,在1米处为0.1±0.1微希沃特/小时,在2米处为0.1±0.0微希沃特/小时。0.5米距离处的剂量率与患者体重显著相关(P<0.02),但与身高或注射活度无关。对于参与整个过程的与患者同住者,假定的估计最大全身剂量为55微希沃特;护理人员为2.9 - 3.4微希沃特;治疗医师为0.2 - 1.8微希沃特;技术人员为0.3 - 0.6微希沃特。上述值低于使用相同方法对用于膝关节滑膜炎的替代RS放射性药物(如镝-165氢氧化铁大颗粒((165)Dy-FHMA)或钬-166((166)Ho-FHMA))以其典型注射活度估算出的值。总之,我们的结果表明,在(90)Y-SC膝关节滑膜切除术中,医疗和非医疗人员所接受的全身辐射剂量如预期的那样远低于公众和受辐射专业人员的最大年度剂量限值。